178 related articles for article (PubMed ID: 12881382)
1. Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation.
Waeber M; Castiglione-Gertsch M; Dietrich D; Thürlimann B; Goldhirsch A; Brunner KW; Borner MM;
Ann Oncol; 2003 Aug; 14(8):1215-21. PubMed ID: 12881382
[TBL] [Abstract][Full Text] [Related]
2. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.
Borner M; Bacchi M; Goldhirsch A; Greiner R; Harder F; Castiglione M; Jungi WF; Thürlimann B; Cavalli F; Obrecht JP
J Clin Oncol; 1994 Oct; 12(10):2071-7. PubMed ID: 7931476
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.
Kuo SH; Huang CS; Kuo WH; Cheng AL; Chang KJ; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1456-64. PubMed ID: 18692329
[TBL] [Abstract][Full Text] [Related]
4. Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
van Hezewijk M; Bastiaannet E; Putter H; Scholten AN; Liefers GJ; Rea D; Hasenburg A; Paridaens R; Hozumi Y; Markopoulos C; Seynaeve C; Jones SE; Marijnen CA; van de Velde CJ
Radiother Oncol; 2013 Aug; 108(2):190-6. PubMed ID: 24044798
[TBL] [Abstract][Full Text] [Related]
5. Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen.
Arriagada R; Spielmann M; Koscielny S; Le Chevalier T; Delozier T; Ducourtieux M; Tursz T; Hill C
Ann Oncol; 2002 Sep; 13(9):1378-86. PubMed ID: 12196363
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.
Aebi S; Gelber S; Anderson SJ; Láng I; Robidoux A; Martín M; Nortier JW; Paterson AH; Rimawi MF; Cañada JM; Thürlimann B; Murray E; Mamounas EP; Geyer CE; Price KN; Coates AS; Gelber RD; Rastogi P; Wolmark N; Wapnir IL;
Lancet Oncol; 2014 Feb; 15(2):156-63. PubMed ID: 24439313
[TBL] [Abstract][Full Text] [Related]
7. Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.
Del Mastro L; Dozin B; Aitini E; Catzeddu T; Baldini E; Contu A; Durando A; Danese S; Cavazzini G; Canavese G; Bruzzi P; Pronzato P; Venturini M;
Ann Oncol; 2008 Feb; 19(2):299-307. PubMed ID: 17947224
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
[TBL] [Abstract][Full Text] [Related]
9. Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.
Fisher B; Jeong JH; Dignam J; Anderson S; Mamounas E; Wickerham DL; Wolmark N
J Natl Cancer Inst Monogr; 2001; (30):62-6. PubMed ID: 11773294
[TBL] [Abstract][Full Text] [Related]
10. Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study.
Veronesi A; Miolo G; Magri MD; Crivellari D; Scalone S; Bidoli E; Lombardi D
BMC Cancer; 2010 May; 10():205. PubMed ID: 20470379
[TBL] [Abstract][Full Text] [Related]
11. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.
Fargeot P; Bonneterre J; Roché H; Lortholary A; Campone M; Van Praagh I; Monnier A; Namer M; Schraub S; Barats JC; Guastalla JP; Goudier MJ; Chapelle-Marcillac I
J Clin Oncol; 2004 Dec; 22(23):4622-30. PubMed ID: 15505276
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
Overgaard M; Jensen MB; Overgaard J; Hansen PS; Rose C; Andersson M; Kamby C; Kjaer M; Gadeberg CC; Rasmussen BB; Blichert-Toft M; Mouridsen HT
Lancet; 1999 May; 353(9165):1641-8. PubMed ID: 10335782
[TBL] [Abstract][Full Text] [Related]
13. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.
Tormey DC; Gray R; Falkson HC
J Natl Cancer Inst; 1996 Dec; 88(24):1828-33. PubMed ID: 8961972
[TBL] [Abstract][Full Text] [Related]
14. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
Polgár C; Fodor J; Major T; Sulyok Z; Kásler M
Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
[TBL] [Abstract][Full Text] [Related]
15. Alternative therapy for elderly patients with breast cancer.
von Rueden DG; Sessions SC
Am Surg; 1994 Jan; 60(1):72-8. PubMed ID: 8273979
[TBL] [Abstract][Full Text] [Related]
16. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of breast conserving surgery for stages I and II breast cancer: experiences at Osaka Medical Center for Cancer and Cardiovascular Diseases.
Komoike Y; Motomura K; Inaji H; Kasugai T; Nose T; Koizumi M; Koyama H
Breast Cancer; 2002; 9(3):248-53. PubMed ID: 12185337
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
Dubsky PC; Jakesz R; Mlineritsch B; Pöstlberger S; Samonigg H; Kwasny W; Tausch C; Stöger H; Haider K; Fitzal F; Singer CF; Stierer M; Sevelda P; Luschin-Ebengreuth G; Taucher S; Rudas M; Bartsch R; Steger GG; Greil R; Filipcic L; Gnant M
J Clin Oncol; 2012 Mar; 30(7):722-8. PubMed ID: 22271481
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
20. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]